These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 23871169)

  • 1. Moving beyond transition outcomes: meta-analysis of remission rates in individuals at high clinical risk for psychosis.
    Simon AE; Borgwardt S; Riecher-Rössler A; Velthorst E; de Haan L; Fusar-Poli P
    Psychiatry Res; 2013 Oct; 209(3):266-72. PubMed ID: 23871169
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Social cognitive functioning in prodromal psychosis: A meta-analysis.
    Lee TY; Hong SB; Shin NY; Kwon JS
    Schizophr Res; 2015 May; 164(1-3):28-34. PubMed ID: 25749019
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Symptomatic and functional remission of subjects at clinical high risk for psychosis: a 2-year naturalistic observational study.
    Lee TY; Kim SN; Correll CU; Byun MS; Kim E; Jang JH; Kang DH; Yun JY; Kwon JS
    Schizophr Res; 2014 Jul; 156(2-3):266-71. PubMed ID: 24815568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical outcomes in individuals at clinical high risk of psychosis who do not transition to psychosis: a meta-analysis.
    Salazar de Pablo G; Soardo L; Cabras A; Pereira J; Kaur S; Besana F; Arienti V; Coronelli F; Shin JI; Solmi M; Petros N; Carvalho AF; McGuire P; Fusar-Poli P
    Epidemiol Psychiatr Sci; 2022 Jan; 31():e9. PubMed ID: 35042573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Adolescents at ultra-high risk for psychosis: long-term outcome of individuals who recover from their at-risk state.
    de Wit S; Schothorst PF; Oranje B; Ziermans TB; Durston S; Kahn RS
    Eur Neuropsychopharmacol; 2014 Jun; 24(6):865-73. PubMed ID: 24636460
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Recovery from an at-risk state: clinical and functional outcomes of putatively prodromal youth who do not develop psychosis.
    Schlosser DA; Jacobson S; Chen Q; Sugar CA; Niendam TA; Li G; Bearden CE; Cannon TD
    Schizophr Bull; 2012 Nov; 38(6):1225-33. PubMed ID: 21825282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Course of clinical high-risk states for psychosis beyond conversion.
    Michel C; Ruhrmann S; Schimmelmann BG; Klosterkötter J; Schultze-Lutter F
    Eur Arch Psychiatry Clin Neurosci; 2018 Feb; 268(1):39-48. PubMed ID: 28054132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Predicting psychosis: meta-analysis of transition outcomes in individuals at high clinical risk.
    Fusar-Poli P; Bonoldi I; Yung AR; Borgwardt S; Kempton MJ; Valmaggia L; Barale F; Caverzasi E; McGuire P
    Arch Gen Psychiatry; 2012 Mar; 69(3):220-9. PubMed ID: 22393215
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Persistence or recurrence of non-psychotic comorbid mental disorders associated with 6-year poor functional outcomes in patients at ultra high risk for psychosis.
    Rutigliano G; Valmaggia L; Landi P; Frascarelli M; Cappucciati M; Sear V; Rocchetti M; De Micheli A; Jones C; Palombini E; McGuire P; Fusar-Poli P
    J Affect Disord; 2016 Oct; 203():101-110. PubMed ID: 27285723
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predicting psychosis in a general adolescent psychiatric sample.
    Lindgren M; Manninen M; Kalska H; Mustonen U; Laajasalo T; Moilanen K; Huttunen M; Cannon TD; Suvisaari J; Therman S
    Schizophr Res; 2014 Sep; 158(1-3):1-6. PubMed ID: 25015028
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High remission rates from an initial ultra-high risk state for psychosis.
    Simon AE; Umbricht D
    Schizophr Res; 2010 Feb; 116(2-3):168-72. PubMed ID: 19854621
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Emotional and behavioral symptomatology reported by help-seeking youth at clinical high-risk for psychosis.
    Thompson E; Kline E; Ellman LM; Mittal V; Reeves GM; Schiffman J
    Schizophr Res; 2015 Mar; 162(1-3):79-85. PubMed ID: 25638728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Neurocognitive function as a possible marker for remission from clinical high risk for psychosis.
    Lee TY; Shin YS; Shin NY; Kim SN; Jang JH; Kang DH; Kwon JS
    Schizophr Res; 2014 Mar; 153(1-3):48-53. PubMed ID: 24529365
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurocognition in clinical high risk young adults who did or did not convert to a first schizophrenic psychosis: a meta-analysis.
    De Herdt A; Wampers M; Vancampfort D; De Hert M; Vanhees L; Demunter H; Van Bouwel L; Brunner E; Probst M
    Schizophr Res; 2013 Sep; 149(1-3):48-55. PubMed ID: 23830855
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Meta-analyzing the prevalence and prognostic effect of antipsychotic exposure in clinical high-risk (CHR): when things are not what they seem.
    Raballo A; Poletti M; Preti A
    Psychol Med; 2020 Dec; 50(16):2673-2681. PubMed ID: 33198845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ultra high-risk state for psychosis and non-transition: a systematic review.
    Simon AE; Velthorst E; Nieman DH; Linszen D; Umbricht D; de Haan L
    Schizophr Res; 2011 Oct; 132(1):8-17. PubMed ID: 21784618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and functional characteristics of youth at clinical high-risk for psychosis who do not transition to psychosis.
    Addington J; Stowkowy J; Liu L; Cadenhead KS; Cannon TD; Cornblatt BA; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Bearden CE; Mathalon DH; Santesteban-Echarri O; Woods SW
    Psychol Med; 2019 Jul; 49(10):1670-1677. PubMed ID: 30176955
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Anxiety in youth at clinical high risk for psychosis.
    McAusland L; Buchy L; Cadenhead KS; Cannon TD; Cornblatt BA; Heinssen R; McGlashan TH; Perkins DO; Seidman LJ; Tsuang MT; Walker EF; Woods SW; Bearden CE; Mathalon DH; Addington J
    Early Interv Psychiatry; 2017 Dec; 11(6):480-487. PubMed ID: 26456932
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Heterogeneity of Psychosis Risk Within Individuals at Clinical High Risk: A Meta-analytical Stratification.
    Fusar-Poli P; Cappucciati M; Borgwardt S; Woods SW; Addington J; Nelson B; Nieman DH; Stahl DR; Rutigliano G; Riecher-Rössler A; Simon AE; Mizuno M; Lee TY; Kwon JS; Lam MM; Perez J; Keri S; Amminger P; Metzler S; Kawohl W; Rössler W; Lee J; Labad J; Ziermans T; An SK; Liu CC; Woodberry KA; Braham A; Corcoran C; McGorry P; Yung AR; McGuire PK
    JAMA Psychiatry; 2016 Feb; 73(2):113-20. PubMed ID: 26719911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Baseline Antipsychotic Dose and Transition to Psychosis in Individuals at Clinical High Risk: A Systematic Review and Meta-Analysis.
    Raballo A; Poletti M; Preti A
    JAMA Psychiatry; 2024 Jul; 81(7):727-730. PubMed ID: 38506802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.